News
Date:
Business Wire: September 11, 2017 – PARIS, France – Gecko Biomedical (“Gecko”), a medical device company developing innovative polymers to support tissue reconstruction, announced today that it has received CE Mark approval for its Setalum™ sealant, allowing the company to market its technology in…
Date:
Business Wire: September 7, 2017 – WATERTOWN, MA, U.S.A. – Lyndra, Inc. (Lyndra) announced today a partnership with Allergan plc to develop orally administered ultra-long-acting (once-weekly) products for the treatment of Alzheimer’s disease. The basis of the collaboration between the Boston-based…
Date:
VANCOUVER, BC, Canada – biOasis Technologies Inc. (OTCQB: BIOAF; TSX.V: BTI), a biopharmaceutical company focused on overcoming the limitations of therapeutic drug delivery across the blood-brain barrier (BBB) and into the central nervous system for the treatment of neurological diseases and…
Date:
PRNewswire: September 6, 2017 – LEXINGTON, MA, U.S.A. – Pulmatrix, Inc. (NASDAQ: PULM), a clinical stage biopharmaceutical company developing innovative inhaled therapies to address serious pulmonary diseases, today announced that it has partnered with Vectura Group plc (LSE: VEC) (“Vectura”) to…
Date:
Business Wire: September 5, 2017 – BALERNA, Switzerland – APR Applied Pharma Research s.a. (“APR”), the Swiss independent developer of science driven and patent protected healthcare products, announced today the results of a preclinical kinetic study showing a physiological absorption of clinically…
Date:
Business Wire: August 29, 2017 – BOSTON, MA, U.S.A. – PureTech Health plc (“PureTech Health” or the “company”, LSE: PRTC), an advanced, clinical-stage biopharmaceutical company, today announced an exclusive licensing agreement with Monash University for a lymphatic targeting platform (the Glyph…
